Edgewise Therapeutics, Inc. - COMMON STOCK (EWTX)

CUSIP: 28036F105

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+11,970,627
Put/Call ratio
101%
SEC-reported price per share
$18.24
Number of holders
126
Value change
+$311,144,088
Number of buys
89
Open additional details 1 more signal available
Number of sells
46
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
107,880,000

Security key

28036F105

Report period

Q1 2024

Institutions

126

Top holders

10

Ownership snapshot

Top reported holders of EWTX - Edgewise Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Novo Holdings A/S
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5 13F Highest disclosed value: $159,364,905 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $159.36M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
Novo Holdings A/S $95.78M
ORBIMED ADVISORS LLC $159.36M
VIKING GLOBAL INVESTORS LP $67.38M
DEERFIELD MANAGEMENT COMPANY, L.P. $43.03M
EcoR1 Capital, LLC $38.22M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Novo Holdings A/S
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$95,781,722
6,071,703 shares
— 14 Sep 2022
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$159,364,905
14,567,176 shares
— 31 Dec 2023
VIKING GLOBAL INVESTORS LP
13F
Company
13F
—
denominator unverified
$67,381,057
6,159,146 shares
— 31 Dec 2023
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$43,028,519
3,933,137 shares
— 31 Dec 2023
EcoR1 Capital, LLC
13F
Company
13F
—
denominator unverified
$38,215,542
3,493,194 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$36,179,784
3,307,110 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
126
Shares
91,602,360
Rows available
126
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
126
Q1 2024 holders
126
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .